Genomics & Omics Analysis - software & AI news

Daily news on software, AI, and companies shaping genomics & omics analysis.

Showing 121 results
Press release cover image

Sep 9, 2026

JAAD Publication Shows Improved Performance of DecisionDx®-SCC

DecisionDx-SCC shows enhanced performance with the integration of select clinicopathologic risk factors, providing a more precise result to support risk-aligned patient managementDecisionDx-SCC's Class 1A (low risk) result demonstrated a 97.3% negative predictive value, supporting confidence in de-escalation decisions, while its Class 2B (highest risk) result identified patients most likely to benefit from adjuvant radiation therapyFRIENDSWOOD, Texas, Sept. 9, 2026 /PRNewswire/ -- Castle Bioscie
A minimalist representation of a DNA strand symbolizing genome sequencing advancements.

Sep 9, 2026

Ultima, NVIDIA, Google Partner on Pangenome-Aware Whole Genome Sequencing

Ultima Genomics, NVIDIA, and Google have joined forces to enhance whole genome sequencing (WGS) through pangenome-aware analysis, aiming to improve genetic variant detection and mapping.This collaboration leverages Ultima's cost-effective sequencing technology alongside NVIDIA's GPU-accelerated computational capabilities and Google’s DeepVariant for pangenome graph alignment. The initiative seeks to make the practical application of pangenome-aware WGS a reality, moving beyond traditional refere
Press release cover image

Sep 9, 2026

Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing

Tenth SBIR award brings Partillion's total non-dilutive federal funding to more than $8 million and supports development of Cell-Cell-seq workflowsLOS ANGELES, Sept. 9, 2026 /PRNewswire/ -- Partillion Bioscience announced a two-year, $2.1 million NIH Small Business Innovation Research (SBIR) award from the National Institute of General Medical Sciences (NIGMS) to expand the company's Cell-Cell-seq workflows. Partillion's 10th SBIR grant brings the company's total non-dilutive federal funding to
Press release cover image

Sep 8, 2026

Stowers Institute partners with Google DeepMind and leading research institutions to help reveal the regulatory language of the human genome

Researchers provided biological expertise and feedback that helped guide the development of a new AI-powered resource released today. For the first time, scientists can explore a comprehensive map of more than 9 billion possible single-letter DNA changes through a web browser, helping them more quickly prioritize and interpret variants that may influence biology and disease and lay groundwork for future treatments. KEY HIGHLIGHTS Developed over several years, AlphaGenome Atlas is a one-petabyte
Minimalist illustration of an RNA molecule and control layer

Sep 8, 2026

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines

RNAV8 Bio has secured funding from ARPA-H to advance the PROPEL initiative, aimed at enhancing RNA medicines through programmable control mechanisms.RNAV8 Bio, known for its AI-driven approach to mRNA design, is collaborating with prestigious labs at Harvard and MIT under a $4.4 million ARPA-H pilot program. The PROPEL initiative seeks to leverage RNA’s natural folding behavior to create a tunable control layer for RNA therapeutics. This effort addresses the existing challenges in predicting the
Press release cover image

Sep 8, 2026

Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order

A successful multi-site ring trial and early access program demonstrate the reproducibility, scalability, and biological insight of the Metabolon Verus™ Metabolomics Profiling Kit across laboratories worldwideMORRISVILLE, N.C., Sept. 8, 2026 /CNW/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced that the Metabolon Verus™ Metabolomic
Next-generation sequencing machine in a laboratory setting with a sample vial on the bench.

Sep 8, 2026

Clean Cells Broadens Viral Safety Testing Portfolio with NGS

Clean Cells has expanded its viral safety testing capabilities by launching a next-generation sequencing (NGS) service, aimed at enhancing the analysis of viral vectors and recombinant preparations. This initiative is bolstered by the acquisition of Xegen, a bioinformatics CRO specializing in NGS data analysis.The integration of Xegen is intended to fortify Clean Cells' bioinformatics infrastructure, which is crucial for ensuring reliable and auditable data management in NGS workflows. CEO Laure
Press release cover image

Sep 8, 2026

New Multi-Site Validation Study Published by Panakeia Reinforces Scalability of AI Multi-Omics Platform

Study confirms diagnostic-grade performance of PANProfiler Breast (ER, PR, HER2) from routine brightfield images; establishing the technology as a scalable foundation for oncology across multiple cancer types and biomarkers Cambridge, UK, September 8, 2026 — Panakeia, a world-leading in silico multi-omics company, today announced the publication of a multi-site clinical validation study in Clinical Breast Cancer. The research demonstrates that its PANProfiler Breast (ER, PR, HER2) software, a UK
DNA helix and magnifying glass illustration

Sep 2, 2026

Deep-Learning Tool Uses Long-Read Sequencing to Detect Cancer Mutations

Researchers at The University of Hong Kong have introduced ClairS, a novel deep-learning tool that enhances the detection of cancer-related mutations using long-read sequencing technology.ClairS addresses the challenges of identifying low-frequency mutations in cancer cells, which are often difficult to analyze with traditional short-read sequencing methods. By leveraging long-read sequencing, the tool can more effectively map complex genomic regions that short-read technologies struggle with. T
Press release cover image

Sep 1, 2026

Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™

eSTRAND RNA QC™ uses nanopore-based direct RNA sequencing to offer multi-attribute RNA characterization.Using direct RNA sequencing, eSTRAND RNA QC reads full-length RNA without requiring reverse transcription or translation.eSTRAND RNA QC simultaneously measures RNA identity, poly(A) tail length, capping efficiency, fragmentation hotspots, and double-stranded RNA.SAN DIEGO, Sept. 1, 2026 /PRNewswire/ -- Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics and AI-e
A minimalist representation of a DNA strand in a flat design style.

Sep 1, 2026

Trends from the Trenches: Rethinking Computational Workflows for Modern Genomics

The landscape of modern genomics is evolving, necessitating a reevaluation of computational workflows to manage the vast data generated by precision medicine and multi-omics approaches.As genomic data increasingly intersects with phenotype, transcriptomics, proteomics, and imaging, researchers are encountering significant challenges in establishing reproducible and standardized methods. In a recent discussion, Ben Busby from NVIDIA emphasized the need for a collaborative approach to software dev
A tissue sample on a microscope slide in a lab setting.

Aug 31, 2026

Spatial Transcriptomics Tools May Link Tumor Organization to Treatment Response

Recent advancements in spatial transcriptomics are enabling researchers to better understand the relationship between tumor organization and treatment response, particularly in cancer therapy.Researchers at the University of Chicago have developed a framework for comparing spatial transcriptomics data across various tumor types, as detailed in their study published in *Cell Reports Medicine*. By analyzing data from 262 solid tumors, they identified recurring multicellular regions, termed "spatia